Three oral and 12 poster presentations demonstrate breadth and progress of AskBio’s gene therapy research and development ...

Press Release Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that its Trials in Progress abstract has been ...

The Symposium of Student Research and Creative Activity was a daylong event for motivated students on April 24 to showcase research projects to guests, staff and other students through a poster-board ...

In April 2025, our partner Jazz announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human ...

Strong Clinical Evidence Supports Use of the Suprachoroidal Platform in Expanding the Standard of Care for the Treatment of Multiple Macular DiseasesALPHARETTA, Ga., May 09, 2025 (GLOBE NEWSWIRE) -- ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity” or "the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

Meaningful and durable increases in functional neutrophils observed over 6-month trial with oral once-daily mavorixafor. Majority of physicians and chronic neutropenia participant ...

Adagene Inc. announced a poster presentation for the ASCO 2025 conference ... company's commitment to sharing advancements in their research, which can enhance visibility and credibility within ...

Our latest posters, at the world's most prestigious gene therapy event, provide critical insights into the safety and efficacy of rAAV-based therapeutics. We support biopharma companies with ...

today announced the publication of 3 abstracts for poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025. In addition to a trial-in-progress study design ...

The 20th annual John Heinrichs Scholarly and Creative Activity Days (SACAD) was held on April 24. Despite an early threat of ...